Analyst firms · BofA Securities · GDRX

BofA Securities GDRX price target and rating history

GoodRx Holdings Inc. (GDRX) · Technology

BofA Securities rates GoodRx Holdings Inc. (GDRX) Underperform with a $4.50 price target, as of its latest action on Jan 2, 2024. It has published 3 rating actions on GDRX since March 2022, including 0 upgrades and 1 downgrade.

Current rating
Underperform
Price target
$4.50
Median target, all firms
Too few
Actions on GDRX
3

BofA Securities price target on GDRX

$28$16$4.502023202420252026
BofA Securities price target on GDRX, each point a stated target, March 2022 to January 2024.

Every BofA Securities rating on GDRX

How other firms rate GDRX

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
JefferiesHold$2.75Jan 22, 2026
BarclaysUnderweight$3Dec 9, 2025

Questions about BofA Securities and GDRX

What is BofA Securities's price target for GDRX?
BofA Securities's latest stated price target for GoodRx Holdings Inc. (GDRX) is $4.50, from its action on Jan 2, 2024.
What is BofA Securities's rating on GDRX?
BofA Securities rates GDRX Underperform, a bearish rating, as of Jan 2, 2024.
When did BofA Securities last change its view on GDRX?
On Jan 2, 2024, BofA Securities downgrades to Underperform from Buy, price target $8 to $4.50.

More GDRX rating histories

All BofA Securities ratingsGDRX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.